Mobin Karimi

1.2k total citations
32 papers, 927 citations indexed

About

Mobin Karimi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mobin Karimi has authored 32 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 16 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Mobin Karimi's work include T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (15 papers) and CAR-T cell therapy research (14 papers). Mobin Karimi is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immune Cell Function and Interaction (15 papers) and CAR-T cell therapy research (14 papers). Mobin Karimi collaborates with scholars based in United States, Canada and Iran. Mobin Karimi's co-authors include Robert S. Negrin, Jeanette Baker, Christopher H. Contag, Taku Kambayashi, Ryosei Nishimura, Robert Zeiser, Emanuela Sega, Janelle A. Olson, Andreas Beilhack and Jeanette Baker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mobin Karimi

32 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mobin Karimi United States 11 524 414 291 198 71 32 927
Sijie Lu United States 14 904 1.7× 688 1.7× 254 0.9× 172 0.9× 97 1.4× 25 1.3k
Weiqing Jing United States 15 479 0.9× 452 1.1× 225 0.8× 248 1.3× 63 0.9× 29 825
Erik Ames United States 15 740 1.4× 488 1.2× 178 0.6× 160 0.8× 38 0.5× 26 965
Yu Kyeong Hwang South Korea 17 486 0.9× 427 1.0× 292 1.0× 95 0.5× 32 0.5× 31 850
Marlana Orloff United States 17 393 0.8× 561 1.4× 358 1.2× 76 0.4× 47 0.7× 80 1.1k
Jan Martínek United States 7 492 0.9× 397 1.0× 244 0.8× 84 0.4× 117 1.6× 14 924
Peggy A. Bulur United States 13 860 1.6× 544 1.3× 302 1.0× 155 0.8× 107 1.5× 27 1.3k
Mara Dottore Australia 18 730 1.4× 380 0.9× 320 1.1× 149 0.8× 58 0.8× 23 1.2k
Felix S. Lichtenegger Germany 18 698 1.3× 684 1.7× 428 1.5× 440 2.2× 109 1.5× 35 1.3k
Federica Costa Italy 16 203 0.4× 376 0.9× 302 1.0× 350 1.8× 38 0.5× 33 821

Countries citing papers authored by Mobin Karimi

Since Specialization
Citations

This map shows the geographic impact of Mobin Karimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mobin Karimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mobin Karimi more than expected).

Fields of papers citing papers by Mobin Karimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mobin Karimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mobin Karimi. The network helps show where Mobin Karimi may publish in the future.

Co-authorship network of co-authors of Mobin Karimi

This figure shows the co-authorship network connecting the top 25 collaborators of Mobin Karimi. A scholar is included among the top collaborators of Mobin Karimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mobin Karimi. Mobin Karimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karthikeyan, Santhosh Kumar, Palanisamy Nallasamy, John L. Cleveland, et al.. (2025). ProteotoxomiRs: Diagnostic and pathologic miRNA signatures for reductive stress induced proteotoxic heart disease. Redox Biology. 81. 103525–103525. 2 indexed citations
2.
Karimi, Mobin, et al.. (2024). LncRNA Linc00261 sponge's miR-33-regulated PI3-kinase in autism disorder. Gene Reports. 38. 102115–102115. 1 indexed citations
3.
Sen, Jyoti Misra, et al.. (2023). TCF-1 negatively regulates the suppressive ability of canonical and noncanonical Tregs. Journal of Leukocyte Biology. 113(5). 489–503. 5 indexed citations
4.
Harris, Rebecca & Mobin Karimi. (2023). Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT. Frontiers in Immunology. 14. 1194984–1194984. 3 indexed citations
5.
Sen, Jyoti Misra, et al.. (2023). TCF-1 Is Required for CD4 T Cell Persistence Functions during AlloImmunity. International Journal of Molecular Sciences. 24(5). 4326–4326. 8 indexed citations
6.
Harris, Rebecca, et al.. (2022). TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses. Cancer Immunology Immunotherapy. 72(6). 1581–1601. 10 indexed citations
7.
Harris, Rebecca, Teresa Gentile, Adam T. Waickman, et al.. (2021). Interleukin‐2‐inducible T‐cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells. SHILAP Revista de lepidopterología. 11(12). e625–e625. 11 indexed citations
8.
Harris, Rebecca, et al.. (2021). Targeting ITK signaling for T cell-mediated diseases. iScience. 24(8). 102842–102842. 17 indexed citations
9.
Huang, Weishan, Rebecca Harris, Hui Xiong, et al.. (2021). Targeting SLP76:ITK interaction separates GVHD from GVL in allo-HSCT. iScience. 24(4). 102286–102286. 7 indexed citations
10.
Roy, Nathan H., et al.. (2020). CrkL is required for donor T cell migration to GvHD target organs. Oncotarget. 11(17). 1505–1514. 5 indexed citations
11.
Huang, Weishan, Rebecca Harris, Aisha Sultana, et al.. (2020). Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT. Frontiers in Immunology. 11. 593863–593863. 18 indexed citations
12.
Karimi, Mobin, et al.. (2019). ITK signaling differentiates GVT and GVHD after allogeneic bone marrow transplantation by regulating IRF-4, JAK/STAT and Eomesodermin expression. The Journal of Immunology. 202(1_Supplement). 69.4–69.4. 1 indexed citations
13.
Karimi, Mobin, Michael H. Bachmann, Ana M. Salicioni, et al.. (2014). Measuring Cytotoxicity by Bioluminescence Imaging Outperforms the Standard Chromium-51 Release Assay. PLoS ONE. 9(2). e89357–e89357. 91 indexed citations
14.
Mousavi, Seyed Ali, et al.. (2009). Comparison of telomerase activity in malignant and benign pleural effusions.. 8(2). 17–23. 2 indexed citations
15.
Abrahamsson, Annelie, Ifat Geron, Jason Gotlib, et al.. (2009). Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation. Proceedings of the National Academy of Sciences. 106(10). 3925–3929. 182 indexed citations
16.
Karimi, Mobin, et al.. (2007). Methods for Imaging Cell Fates in Hematopoiesis. Methods in molecular medicine. 134. 17–34. 10 indexed citations
17.
Abrahamsson, Annelie, Ifat Geron, Jason Gotlib, et al.. (2007). Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation.. Blood. 110(11). 775–775. 3 indexed citations
18.
Chan, John K., Chad A. Hamilton, Michael K. Cheung, et al.. (2006). Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study. Clinical Cancer Research. 12(6). 1859–1867. 106 indexed citations
19.
Karimi, Mobin, Thai M. Cao, Jeanette Baker, et al.. (2005). Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells. The Journal of Immunology. 175(12). 7819–7828. 105 indexed citations
20.
McCaffrey, Anton P., Leonard Meuse, Mobin Karimi, Christopher H. Contag, & Mark A. Kay. (2003). A Potent and Specific Morpholino Antisense Inhibitor of Hepatitis C Translation in Mice. Hepatology. 38(2). 503–508. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sijie Lu Breakdown of academic impact, for papers by Weiqing Jing Breakdown of academic impact, for papers by Erik Ames Breakdown of academic impact, for papers by Yu Kyeong Hwang Breakdown of academic impact, for papers by Marlana Orloff Breakdown of academic impact, for papers by Jan Martínek Breakdown of academic impact, for papers by Peggy A. Bulur Breakdown of academic impact, for papers by Mara Dottore Breakdown of academic impact, for papers by Felix S. Lichtenegger Breakdown of academic impact, for papers by Federica Costa
Rankless by CCL
2026